Latest and Past News
-
WFH 2022 Congress experience from a social worker’s perspective
by Karen Mantyka, Social worker, Saskatchewan Bleeding Disorders Program This year marked the 35th WFH World Congress, which was held in Montreal, Canada where thousands...
-
The CHS appoints new CEO
CLICK HERE to read the official announcement from CHS President, Wendy Quinn.
-
2021 CHS Annual Report
Please CLICK HERE to access the 2021 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking...
-
CHS reacts to Health Canada decision on relaxing donor selection criteria
April 28, 2022 (Montreal) – “The Canadian Hemophilia Society (CHS) is disappointed that Health Canada has not followed our advice regarding the changes to donor...
-
Committed BC health care providers receive two awards
by Wendy Quinn, CHS President A few days ago I received an e-mail with the subject “Exciting news and accomplishments in BC.” I immediately opened...
-
CBS supplier contracts for rFVIII and rFIX take effect April 4
March 30, 2022, Ottawa – Canadian Blood Services’ contracts with suppliers of recombinant factor VIII and IX for the 2022-2025 period take effect on April...
-
The 10 key takeaways from CHS advocacy efforts to obtain access to emicizumab (Hemlibra)
by David Page, CHS National Director of Health Policy The Canadian Hemophilia Society (CHS), its chapters and members have expended great efforts to advocate for...
-
Update on products in the pipeline
Updated charts for products in the pipeline have been uploaded on the CHS website. The CHS publishes four charts, one each for clotting factor concentrates, inhibitor...
-
Hemlibra approved for all those with severe hemophilia A in Quebec – Access starts April 1
by David Page, CHS National Director of Health Policy March 1, 2022, Montréal – The Canadian Hemophilia Society (CHS) was informed yesterday by Héma-Québec that access...
-
Letter to the Embassy of the Russian Federation in Canada
Please CLICK HERE to read the letter sent to the Russian Ambassador in Canada by the Canadian Hemophilia Society and the World Federation of Hemophilia...
-
Update on access to coagulation products for hemophilia A and B
by David Page, CHS National Director of Health Policy Access to a wide range of coagulation products is expanding in the provinces and territories served by...
-
David Page: Congratulations on 20 years of service!
Dear David, This is your 20th anniversary with the CHS and we would like to take this time to extend our deepest gratitude for all...
-
All About Mild Hemophilia
Mild hemophilia can be very serious and even life-threatening if injuries or bleeds are not treated promptly and adequately. The past few years, a lot...
-
Has the bleeding disorder world fundamentally changed?
by David Page, CHS National Director of Health Policy Given recent advances in therapies for inherited bleeding disorders, especially hemophilia A and B, I have...